OMB.report

Federal forms, ICRs, and supporting documents

OMB control number

Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials

OMB 0910-0902 · HHS/FDA.

OMB 0910-0902

Latest Forms, Documents, and Supporting Material

Latest forms, documents, and information collections
DocumentType
Supporting Statement Part B - Secondary Claim Disclosures and Biosimilar Disclosures 2021.docxSupporting Statement B
Supporting Statement Part A - Secondary Claim Disclosures and Biosimilar Disclosures 2021.docxSupporting Statement A
Phase 2 Main Study Completes (Consumers) Other-Informed Consent
Phase 2 - Main Study Completes (HCPs) Other-Informed Consent
Phase 2 - Main Study Screeners (Consumers) Other-Recruitment Email and Screeners
Phase 2 - Main Study Screener (HCPs) Other-Recruitment Email and Screeners
Phase 1 - Main Study Completes (Consumers) Other-Informed Consent
Phase 1 - Main Study Completes (HCPs) Other-Informed Consent
Phase 1 - Main Study Screeners (Consumers) Other-Recruitment Email and Screeners
Phase 1 - Main Study Screeners (HCPs) Other-Recruitment Email and Screeners
Phase 2 - Pretest Completes (Consumers) Other-Informed Consent
Phase 2 - Pretest Completes (HCPs) Other-Informed Consent
Phase 2 - Pretest Screeners (Consumers) Other-Recruitment Email and Screeners
Phase 2 Pretest Screeners (HCPs) Other-Recruitment Email and Screeners
Phase 1 - Pretest Completes (Consumers) Other-Informed Consent
Phase 1 - Pretest Completes (HCPs) Other-Informed Consent
Phase 1 - Pretest Screeners (Consumers) Other-Recruitment Email and Screener 1 and 2
Phase 1 - Pretest Screener (HCPs) Other-Recruitment Email and Screeners 1 and 2

All Historical Document Collections

Historical document collections
ReferenceFilingReceivedConcludedAction
202109-0910-005 New collection (Request for a new OMB Control Number) 2021-09-16 Approved without change